Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CVS HEALTH CorpCVS · Entity 2884 | Director | May 14, 2026 | May 15, 2026 |
| RAYONIER ADVANCED MATERIALS INC.RYAM · Entity 5392 | Director | May 21, 2020 | May 21, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CVS HEALTH Corp
Report date May 14, 2026 · Filed May 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 129,316 |
Reported balance
After 2026-05-14 transaction · row 1
1 source rowRow 1 · 2026-05-14 · Grant · Acquired 1,544 · Balance 129,316 F1: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan.
RAYONIER ADVANCED MATERIALS INC.
Report date May 21, 2020 · Filed May 21, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 108,450 |
Reported balance
After 2020-05-21 transaction · row 1
1 source rowRow 1 · 2020-05-21 · Exercise / conversion · Acquired 13,258 · Balance 108,450 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2020-05-21 | Direct | 0 |
Reported balance
After 2020-05-21 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2020-05-21 · Exercise / conversion · Disposed 13,258 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of RYAM common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of RYAM common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 02, 2011 Filed Nov 4, 2011 20:00 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 139 | $35.77 | $4,972.03 |
DisclosureSEC source: 0001127602-11-028653 · form4.xml · nonDerivative · entry 1 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,395 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| May 11, 2011 Filed May 13, 2011 20:08 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 3,466.6667 | $37.50 Strike: $0.00 | $130,000.00 |
DisclosureSEC source: 0001127602-11-016266 · form4.xml · derivative · entry 2 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,551.021 Underlying: Common Stock · 3,466.6667 shares Expires not disclosed F2 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2010 Incentive Compensation Plan. F3 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. F3 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 11, 2011 Filed May 13, 2011 20:08 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 133 | $37.50 | $4,987.50 |
DisclosureSEC source: 0001127602-11-016266 · form4.xml · nonDerivative · entry 1 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,256 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| November 04, 2010 Filed Nov 5, 2010 20:36 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 4,125.6744 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-027132 · form4.xml · derivative · entry 1 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,001.3764 Underlying: Common Stock · 4,125.6744 shares Expires not disclosed F1 · shares: Consists of share credits acquired for deferral of semi-annual compensation, at the market price, pursuant to the 2010 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 12, 2010 Filed May 14, 2010 20:07 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 3,579.2952 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-014349 · form4.xml · derivative · entry 1 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,732.6388 Underlying: Common Stock · 3,579.2952 shares Expires not disclosed F1 · shares: Consists of share credits acquired for deferral of semi-annual compensation, at the market price, pursuant to the 2010 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. Read SEC document |
| December 30, 2009 Filed Dec 30, 2009 21:13 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 46,846 | $0.00 Strike: $6.66 | $0.00 |
DisclosureSEC source: 0001127602-09-026312 · form4.xml · derivative · entry 2 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 46,846 shares Expires 2011-03-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| December 30, 2009 Filed Dec 30, 2009 21:13 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 46,846 | $6.66 | $311,994.36 |
DisclosureSEC source: 0001127602-09-026312 · form4.xml · nonDerivative · entry 1 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,123 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2009 Filed Nov 6, 2009 21:03 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 3,596.1272 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-09-021993 · form4.xml · derivative · entry 2 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,097.7264 Underlying: Common Stock · 3,596.1272 shares Expires not disclosed F1 · shares: Consists of share credits acquired for deferral of semi-annual compensation, at the market price, pursuant to the 1997 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 06, 2009 Filed May 8, 2009 20:03 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 4,067.5845 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-09-010980 · form4.xml · derivative · entry 1 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,484.9645 Underlying: Common Stock · 4,067.5845 shares Expires not disclosed F1 · shares: Consists of share credits acquired for deferral of semi-annual compensation at the market price pursuant to the 1997 Incentive Compensation plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 05, 2008 Filed Nov 7, 2008 21:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 4,235.9075 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-08-008957 · form4.xml · derivative · entry 2 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,235.9075 Underlying: Common Stock · 4,235.9075 shares Expires not disclosed F1 · shares: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1997 Incentive Compensation plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 07, 2008 Filed May 8, 2008 21:11 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 3,130.2673 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000064803-08-000053 · doc.xml · derivative · entry 2 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,130.2673 Underlying: Common Stock · 3,130.2673 shares Expires not disclosed F2 · shares: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1997 Incentive Compensation Plan. F3 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. F3 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. Read SEC document |
| May 07, 2008 Filed May 8, 2008 21:11 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 4,000 | $41.53 | $166,120.00 |
DisclosureSEC source: 0000064803-08-000053 · doc.xml · nonDerivative · entry 1 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,277 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees. Read SEC document |
| March 05, 2008 Filed Mar 6, 2008 21:23 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 73 | $40.28 | $2,940.44 |
DisclosureSEC source: 0000064803-08-000032 · doc.xml · nonDerivative · entry 2 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,277 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. Read SEC document |
| March 04, 2008 Filed Mar 6, 2008 21:23 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 24 | $40.92 | $982.08 |
DisclosureSEC source: 0000064803-08-000032 · doc.xml · nonDerivative · entry 1 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,204 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. Read SEC document |
| February 12, 2008 Filed Feb 13, 2008 21:24 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 48 | $40.36 | $1,937.28 |
DisclosureSEC source: 0000064803-08-000020 · doc.xml · nonDerivative · entry 1 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,180 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. Read SEC document |
| January 09, 2008 Filed Jan 10, 2008 21:25 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 105 | $37.19 | $3,904.95 |
DisclosureSEC source: 0000064803-08-000003 · doc.xml · nonDerivative · entry 2 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,132 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. Read SEC document |
| January 08, 2008 Filed Jan 10, 2008 21:25 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 53 | $37.53 | $1,989.09 |
DisclosureSEC source: 0000064803-08-000003 · doc.xml · nonDerivative · entry 1 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,027 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. Read SEC document |
| November 07, 2007 Filed Nov 8, 2007 21:52 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 804 | $41.64 | $33,478.56 |
DisclosureSEC source: 0000064803-07-000164 · doc.xml · nonDerivative · entry 2 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 926 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. Read SEC document |
| November 07, 2007 Filed Nov 15, 2007 21:30 UTC Amendment | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 852 | $41.64 | $35,477.28 |
DisclosureSEC source: 0000064803-07-000179 · doc.xml · nonDerivative · entry 2 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 974 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. Read SEC document |
| November 06, 2007 Filed Nov 8, 2007 21:52 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 23 | $41.82 | $961.86 |
DisclosureSEC source: 0000064803-07-000164 · doc.xml · nonDerivative · entry 1 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. Read SEC document |
| November 06, 2007 Filed Nov 15, 2007 21:30 UTC Amendment | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 23 | $41.82 | $961.86 |
DisclosureSEC source: 0000064803-07-000179 · doc.xml · nonDerivative · entry 1 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. Read SEC document |
| October 29, 2007 Filed Oct 31, 2007 19:55 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 23 | $41.83 | $962.09 |
DisclosureSEC source: 0000064803-07-000156 · doc.xml · nonDerivative · entry 1 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. Read SEC document |
| September 26, 2007 Filed Sep 27, 2007 20:20 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 76 | $39.19 | $2,978.44 |
DisclosureSEC source: 0000064803-07-000149 · doc.xml · nonDerivative · entry 1 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 21:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 33,726 | $0.00 Strike: $27.12 | $0.00 |
DisclosureSEC source: 0000064803-07-000144 · doc.xml · derivative · entry 12 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 33,726 shares Expires 2016-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 21:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 33,739 | $0.00 Strike: $20.23 | $0.00 |
DisclosureSEC source: 0000064803-07-000144 · doc.xml · derivative · entry 11 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 33,739 shares Expires 2015-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 21:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 46,856 | $0.00 Strike: $13.41 | $0.00 |
DisclosureSEC source: 0000064803-07-000144 · doc.xml · derivative · entry 10 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 46,856 shares Expires 2014-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 21:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 10,679 | $0.00 Strike: $9.17 | $0.00 |
DisclosureSEC source: 0000064803-07-000144 · doc.xml · derivative · entry 9 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,170 Underlying: Common Stock · 10,679 shares Expires 2013-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 21:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 125,000 | $37.75 | $4,718,762.50 |
DisclosureSEC source: 0000064803-07-000144 · doc.xml · nonDerivative · entry 6 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 21:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 38,751 | $37.75 | $1,462,850.25 |
DisclosureSEC source: 0000064803-07-000144 · doc.xml · nonDerivative · entry 5 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 F1 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 21:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 33,726 | $27.12 | $914,649.12 |
DisclosureSEC source: 0000064803-07-000144 · doc.xml · nonDerivative · entry 4 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,751 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 21:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 33,739 | $20.23 | $682,539.97 |
DisclosureSEC source: 0000064803-07-000144 · doc.xml · nonDerivative · entry 3 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,025 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 21:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 46,856 | $13.41 | $628,338.96 |
DisclosureSEC source: 0000064803-07-000144 · doc.xml · nonDerivative · entry 2 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,286 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 21:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 10,679 | $9.17 | $97,926.43 |
DisclosureSEC source: 0000064803-07-000144 · doc.xml · nonDerivative · entry 1 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,430 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 21:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 33,726 | $0.00 Strike: $27.12 | $0.00 |
DisclosureSEC source: 0000064803-07-000146 · doc.xml · derivative · entry 12 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 33,726 shares Expires 2016-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 21:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 33,739 | $0.00 Strike: $20.23 | $0.00 |
DisclosureSEC source: 0000064803-07-000146 · doc.xml · derivative · entry 11 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 33,739 shares Expires 2015-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 21:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 46,856 | $0.00 Strike: $13.41 | $0.00 |
DisclosureSEC source: 0000064803-07-000146 · doc.xml · derivative · entry 10 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 46,856 shares Expires 2014-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 21:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 10,679 | $0.00 Strike: $9.17 | $0.00 |
DisclosureSEC source: 0000064803-07-000146 · doc.xml · derivative · entry 9 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,170 Underlying: Common Stock · 10,679 shares Expires 2013-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 21:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 125,000 | $37.75 | $4,718,762.50 |
DisclosureSEC source: 0000064803-07-000146 · doc.xml · nonDerivative · entry 6 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 21:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 38,751 | $37.75 | $1,462,850.25 |
DisclosureSEC source: 0000064803-07-000146 · doc.xml · nonDerivative · entry 5 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 F1 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 21:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 33,726 | $27.12 | $914,649.12 |
DisclosureSEC source: 0000064803-07-000146 · doc.xml · nonDerivative · entry 4 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,751 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 21:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 33,739 | $20.23 | $682,539.97 |
DisclosureSEC source: 0000064803-07-000146 · doc.xml · nonDerivative · entry 3 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,025 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 21:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 46,856 | $13.41 | $628,338.96 |
DisclosureSEC source: 0000064803-07-000146 · doc.xml · nonDerivative · entry 2 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,286 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 21:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 10,679 | $9.17 | $97,926.43 |
DisclosureSEC source: 0000064803-07-000146 · doc.xml · nonDerivative · entry 1 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,430 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| July 11, 2007 Filed Jul 12, 2007 20:35 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 27 | $36.18 | $976.86 |
DisclosureSEC source: 0000064803-07-000132 · doc.xml · nonDerivative · entry 1 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,751 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| June 25, 2007 Filed Jun 27, 2007 20:27 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 27 | $36.31 | $980.37 |
DisclosureSEC source: 0000064803-07-000125 · doc.xml · nonDerivative · entry 1 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,724 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| June 14, 2007 Filed Jun 15, 2007 18:45 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 26 | $37.26 | $968.76 |
DisclosureSEC source: 0000064803-07-000121 · doc.xml · nonDerivative · entry 1 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,697 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| May 09, 2007 Filed May 10, 2007 20:33 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 7,586 | $38.02 | $288,419.72 |
DisclosureSEC source: 0000064803-07-000097 · doc.xml · nonDerivative · entry 1 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,671 F1 · kind: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:48 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 33,726 | $0.00 Strike: $27.12 | $0.00 |
DisclosureSEC source: 0000064803-07-000061 · doc.xml · derivative · entry 8 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,726 Underlying: Common Stock · 33,726 shares Expires 2016-03-01 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:48 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 33,739 | $0.00 Strike: $20.23 | $0.00 |
DisclosureSEC source: 0000064803-07-000061 · doc.xml · derivative · entry 7 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,739 Underlying: Common Stock · 33,739 shares Expires 2015-03-01 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| March 22, 2007 Filed Mar 26, 2007 20:48 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 46,856 | $0.00 Strike: $13.41 | $0.00 |
DisclosureSEC source: 0000064803-07-000061 · doc.xml · derivative · entry 6 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,856 Underlying: Common Stock · 46,856 shares Expires 2014-01-02 F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.